Clinical Trials Browser

Carcinoma, Endometrioid

NCT04604613 2026-03-09

Prediction of Recurrence Among Low Risk Endometrial Cancer Patients

Active not recruiting

518 enrolled

Gynecologic

FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma

NCT06191133 2025-10-02

Fenofibrate in Patients With Cervical Intraepithelial Neoplasia and Invasive Cervical Carcinoma

Phase 1 Recruiting

24 enrolled

Gynecologic

Uterine Cervical Dysplasia

NCT00005095 2025-02-28

Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

Recruiting

6,000 enrolled

BreastGynecologicSarcoma

Carcinoma, Ovarian Epithelial, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Sarcoma, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Myofibroma, Hereditary Breast and Ovarian Cancer Syndrome

NCT06752135 2024-12-30

HRCC1

Terminated

97 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT06576362 2024-08-30

EFIBIA

Phase NA Not yet recruiting

250 enrolled

Disease, Leiomyoma

NCT04990076 2024-07-03

MUSA1

Recruiting

1,500 enrolled

Myofibroma

NCT03694834 2023-11-28

Window of Opportunity Pilot Study of Pembrolizumab in Obesity-driven Endometrial Cancer

Phase EARLY_PHASE1 Terminated

3 enrolled

Gynecologic

Uterine Neoplasms, Endometrial Neoplasms

NCT04120649 2022-08-25

Different Risk Stratification Models for Prediction of Lymph Node Involvement in Endometrial Carcinoma

Completed

50 enrolled

Gynecologic

Endometrial Neoplasms

NCT05261165 2022-03-02

Effect of a Uterine Manipulator on the Incidence of Lymphovascular Propagation (LVSI) in Treatment of Endometrial Cancer

Completed

170 enrolled

Gynecologic

Endometrial Neoplasms

NCT02260752 2020-11-18

COMPARE-UF

Completed

3,094 enrolled

Leiomyoma

NCT02059954 2018-04-17

Vaginal vs. Laparoscopic Hysterectomy

Phase NA Completed

100 enrolled

Leiomyoma, Metrorrhagia, Myofibroma

NCT00610740 2017-12-28

CerviPrep for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial, Cervical, or Ovarian Epithelial Cancer

Phase 2 Completed

18 enrolled 8 charts

Gynecologic

Carcinoma, Ovarian Epithelial, Uterine Cervical Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT02281487 2017-05-30

HYSTUB

Phase NA Completed

105 enrolled

Gynecologic

Ovarian Neoplasms

NCT02422563 2015-04-21

NACOPRAD

Phase 3 Unknown

534 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT01363466 2011-06-01

Evaluation of Hysterectomy After Chemoradiation Therapy for Stage IB2/II Cervical Cancer

Phase 3 Terminated

61 enrolled

Gynecologic

Adenocarcinoma, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Carcinoma, Adenosquamous

NCT00100191 2005-06-24

Emmy Trial: Uterine Artery Embolization (UAE) Versus Hysterectomy for Uterine Fibroids

Phase 3 Completed

120 enrolled

Gynecologic

Leiomyoma, Menorrhagia, Uterine Neoplasms

Clinical Trials

SENTIRAD

Prediction of Recurrence Among Low Risk Endometrial Cancer Patients

Fenofibrate in Patients With Cervical Intraepithelial Neoplasia and Invasive Cervical Carcinoma

Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

HRCC1

EFIBIA

MUSA1

Window of Opportunity Pilot Study of Pembrolizumab in Obesity-driven Endometrial Cancer

Different Risk Stratification Models for Prediction of Lymph Node Involvement in Endometrial Carcinoma

Effect of a Uterine Manipulator on the Incidence of Lymphovascular Propagation (LVSI) in Treatment of Endometrial Cancer

COMPARE-UF

Vaginal vs. Laparoscopic Hysterectomy

CerviPrep for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial, Cervical, or Ovarian Epithelial Cancer

HYSTUB

NACOPRAD

Evaluation of Hysterectomy After Chemoradiation Therapy for Stage IB2/II Cervical Cancer

Emmy Trial: Uterine Artery Embolization (UAE) Versus Hysterectomy for Uterine Fibroids